| PS-DHA | Placebo | ||
---|---|---|---|---|
Adverse event | Number of related or probably related adverse events | Number of not-related or probably not related adverse events | Number of related or probably related adverse events | Number of not-related or probably not related adverse events |
Adverse events among study drop-outs | Â | Â | Â | Â |
Gastrointestinal discomfort | 4 | Â | 1 | Â |
Rush | 1 | Â | Â | Â |
Increased appetite and weight | Â | Â | 1 | Â |
Strange general feeling | Â | Â | 1 | Â |
Headache | Â | Â | 2 | Â |
dizziness | Â | Â | 2 | Â |
Mood swings | Â | Â | 1 | Â |
SUM | 5 events in 5 participants | Â | 8 events in 5 participants | Â |
Adverse events among study completers | Â | Â | Â | Â |
Gastrointestinal discomfort | 9 | 3 | 1 | 2 |
Weight loss | 1 | 1 | Â | Â |
Gastritis | Â | 1 | Â | Â |
Headache | 1 | 1 | Â | Â |
Pneumonia | Â | 2 | Â | Â |
Hypertension | Â | 2 | Â | 1 |
Hypothyroidism | Â | 1 | Â | Â |
Back pain | Â | 1 | Â | Â |
Leg wound | Â | 1 | Â | Â |
Redness in the mouth | Â | Â | 1 | Â |
Pruritus | Â | Â | 1 | Â |
Eyes inflammation | Â | Â | Â | 1 |
SUM | 11 events in 5 participants | 13 events in 10 participants | 3 events in 3 participants | 4 events in 3 participants |